EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy

Minmin Wang, Linzi Jia, Xiangpeng Dai iD, Xiaoling Zhang

Molecular Oncology · 2024-08 · 18 (8) · 1821-1848

DOI: 10.1002/1878-0261.13621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 08.03.2024. Verfasst von Minmin Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR‐T) cell therapy is a newly developed immunotherapy strategy and has achieved satisfactory outcomes in the treatment of hematological malignancies. However, some adverse effects related to CAR‐T cell therapy have to be resolved before it is widely used in clinics as a cancer treatment. Furthermore, the application of CAR‐T cell therapy in the treatment of solid tumors has been hampered by numerous limitations. Therefore, it is essential to explore novel strategies to improve the therapeutic effect of CAR‐T cell therapy. In this review, we summarized the recently developed strategies aimed at optimizing the generation of CAR‐T cells and improving the anti‐tumor efficiency of CAR‐T cell therapy. Furthermore, the discovery of new targets for CAR‐T cell therapy and the combined treatment strategies of CAR‐T cell therapy with chemotherapy, radiotherapy, cancer vaccines and nanomaterials are highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveNeoplasmsReceptors, Chimeric AntigenHumansAnimalsImmunotherapyT-LymphocytesCombined Modality TherapyCancer Vaccines

Stichwörter der Autor:innen

CAR‐T cellCRISPR/Cas9cancer vaccinecombined therapyimmunotherapytumor microenvironment

Substanzen

Receptors, Chimeric AntigenCancer Vaccines

Autor:innen und Institutionen

  • Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China.
  • National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China.
  • Department of General Medicine, Shanxi Province Cancer Hospital, Taiyuan, China.

ORCID-Profile: Xiangpeng Dai

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province

Zitieren

APA

Wang, M., Jia, L., Dai, X., & Zhang, X. (2024). Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy. Molecular Oncology, 18(8), 1821-1848. https://doi.org/10.1002/1878-0261.13621

Vancouver

Wang M, Jia L, Dai X, Zhang X. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy. Molecular Oncology. 2024;18(8):1821-1848. doi:10.1002/1878-0261.13621

BibTeX
@article{Wang2024,
  author = {Wang, Minmin and Jia, Linzi and Dai, Xiangpeng and Zhang, Xiaoling},
  title = {Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy},
  journal = {Molecular Oncology},
  year = {2024},
  volume = {18},
  number = {8},
  pages = {1821--1848},
  doi = {10.1002/1878-0261.13621}
}
Kostenlos starten →